Henry Schein reports record-breaking performance for Q2 2015

Henry Schein has achieved record results for the second quarter of 2015, with net sales for the quarter coming to $2.6 billion (1.67 billion pounds).

This was up by 0.5 percent on Q2 2014, with a growth rate of 7.5 percent in local currencies offset by a seven percent decline caused by the strength of the US dollar against various foreign currencies, particularly the euro.

In local currency terms, each of its main businesses – dental, animal health, medical and technology and value-added services – experienced year-on-year growth, with the medical division seeing the most pronounced improvement.

For the full year, the company has affirmed its earnings guidance range and expects that its ongoing restructuring activities will continue to have a favourable impact on its ongoing financial performance.

Stanley Bergman, chairman of the board and chief executive officer of Henry Schein, said: "Our second-quarter financial results were solid, with internal sales growth in local currencies in each of our four business groups … Overall the global markets we serve were healthy, and we believe we continued to gain market share."

Henry Schein climbed to 287th position on the Fortune 500 earlier this year and also joined the Standard and Poor's 500 for the first time.